explore -WSS

explore

author：focus 2025-08-27 18:59:37 - browse：62817

A page of braille. -- health tech coverage from STAT — Adobe

Katie Keim was diagnosed with type 1 diabetes in 1967 when she was eight, well before the era of insulin pumps or even reliable home testing. The condition started eating away at her vision 20 years later. By the time she was 36, her sight was completely gone.

Keim had lived an independent life as a child despite her illness. Her summers were spent exploring oceans with her family, not at diabetic summer camps. Blindness, though, changed every aspect of her life — including her ability to manage her diabetes. Her first insulin pump had tactile buttons, but all the pumps that came to replace it had digital screens.

“Blind people cannot independently and safely manage our lives through the technology that’s available in home medical devices,” Keim said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： People with substance use disorder deserve online privacy

focus

WSS

People with substance use disorder deserve online privacy

A public scorecard can help hold safety

Akili changes sales model for its ADHD video game treatment

Free Covid tests will again be offered to all U.S. households

Key House panel plots a new health care package

Eli Lilly CEO gives to Mike Pence presidential super PAC

knowledge

explore

explore

The cancer drug shortage isn’t new — and neither are the solutions

'A game

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Google and Epic fight stronger regulation of AI in health care

ChatGPT in medicine: STAT answers readers' burning questions

Neurocrine congenital adrenal hyperplasia trial succeeds

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

A public scorecard can help hold safety

23andMe had bad news about my health. I wish a person had delivered it

Chamber of Commerce, DOJ clash in court over drug prices

focus

What happened to the House vote on health price transparency?

PBMs drew scrutiny in House hearing — and so did pharma

Custom gene therapy hints at new path for rare disease treatments

Cosmetics set for new safety regulation. Why the industry is on board

FDA panel to weigh safety of artificial wombs for preterm births

Fed up with FDA, ALS advocates consider a take

focus

focus

leisure time

hotspot